Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes
about
Islet inflammation: a unifying target for diabetes treatment?α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.Gut microbiota and type 1 diabetesModulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade.Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 DiabetesChronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.Interleukin-6 (IL-6) mediated the increased contraction of distal colon in streptozotocin-induced diabetes in rats via IL-6 receptor pathwayIncreased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes.Increase in peripheral blood mononuclear cell Toll-like receptor 2/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration.Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trialsThe multiple origins of Type 1 diabetes.Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytesGevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?Redox stress unbalances the inflammatory cytokine network: role in autoinflammatory patients and healthy subjects.High-fat meals induce systemic cytokine release without evidence of endotoxemia-mediated cytokine production from circulating monocytes or myeloid dendritic cells.Targeting Innate Immunity for Type 1 Diabetes Prevention.NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count.MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling.Targeting innate immunity for treatment of type 1 diabetes.The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.
P2860
Q26860847-F2EC8EEF-D892-4E53-BF37-1D03EB605297Q33999020-30977AE6-10DE-4185-8692-4778257847DFQ34785097-9276D73C-0D5F-4DB9-A15A-204995EE4674Q34996033-240D29CC-3680-4E20-A25D-7C358AEF663AQ35661927-EA31C786-EB93-483F-AEB0-BE86D798DA5DQ35773292-8806920B-2F72-43C6-A0F7-F89E5FB49FD5Q35853885-A3FD02A8-3B9D-45EB-A71B-A20B137D0602Q36335960-45195A33-1DF4-49B8-99B6-79EF2CE83071Q37088215-59D63ED6-EDE7-4BF5-B66A-466A5D11E18CQ37091562-E1BF728F-DDEE-4AE1-978C-D597AF3A60CDQ37307777-540D1B9B-7A82-4044-A9AB-0DFF9F277657Q38062580-9F2D17CC-E5A0-4657-83A9-1F6BA26DA0D5Q38117282-29DBB747-2614-4085-8237-328425D20BAAQ38235580-C2E75F9D-A423-4E35-B163-DDCBA391CD99Q38551809-09604F42-A85D-4AB8-A6F8-2ADB930506A6Q41757512-DDA4DFD8-B12C-48DA-98F9-37FEAC71026EQ41928977-3B4DFB87-A72C-4D6A-827F-115E19A10C8DQ45028780-23DB68DE-291C-4719-85EE-2E0131B2745EQ45348999-43C87500-44E7-450A-ACFA-5BE7DF0752ADQ48055643-7B0082AE-8060-4EB7-8031-141E990783B8Q50531937-F1C53F7F-283D-4C2B-A344-CEE9AEE649C0
P2860
Dysregulated Toll-like receptor-induced interleukin-1β and interleukin-6 responses in subjects at risk for the development of type 1 diabetes
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@ast
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@en
type
label
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@ast
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@en
prefLabel
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@ast
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@en
P2093
P2860
P356
P1433
P1476
Dysregulated Toll-like recepto ...... development of type 1 diabetes
@en
P2093
Aimon K Alkanani
Danny Zipris
Kathleen Waugh
Peter A Gottlieb
P2860
P304
P356
10.2337/DB12-0099
P407
P577
2012-06-29T00:00:00Z